Alnylam Pharmaceuticals Inc (ALNY) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Alnylam Pharmaceuticals Inc   (NASDAQ: ALNY)
 

Alnylam Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Alnylam Pharmaceuticals Inc inventory turnover ratio, the Alnylam Pharmaceuticals Inc 's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 10.38 in the first quarter 2026, a new company high. Average inventory processing period, for the Alnylam Pharmaceuticals Inc in Mar 31 2026 quarter, has decreased to 35 days, compare to 40 days, in the Dec 31 2025 quarter.

Within Healthcare sector 32 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2026, to 335, from total ranking in the fourth quarter 2025 at 468.

ALNY Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Alnylam Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ALNY Inventory Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Inventory Growth 28.12 % 5.36 % -0.79 % -14.64 % -30.22 %
Y / Y Cost of Sales Growth 195.68 % 160.81 % 140.58 % 111.13 % 28.51 %
Inventory Turnover Ratio (TTM) 10.38 9.17 7.04 5.44 4.24
ALNY's Total Ranking # 335 # 468 # 468 # 415 # 670
Average inventory processing period 35 40 52 67 86
Seq. Inventory Growth 1.58 % 9.73 % 5.15 % 9.31 % -16.47 %
Seq. Cost of Sales Growth -22.49 % 35.74 % 38.87 % 102.37 % -31.63 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 6
Healthcare Sector # 33
Overall Market # 335

Inventory Turnover Ratio Statistics
High Average Low
10.38 2.58 0.35
(Mar 31 2026)   (Jun 30 2019)



ALNY Company Profile >> Back to ALNY Efficiency Comparisons >> Compare ALNY Inventory Turnover Ratio to its Competitors

Financial Statements
Alnylam Pharmaceuticals Inc 's Inventories $ 84 Millions Visit ALNY's Balance sheet
Alnylam Pharmaceuticals Inc 's Cost of Revenues TTM $ 815 Millions Visit ALNY's Income Statement
What are ALNY's Sales? Visit ALNY's Sales by Segment

Other Inventory Turnover Ratios
Alnylam Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ALNY's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ALNY's Competitors
Inventory Turnover Ratio for ALNY's Suppliers
Inventory Turnover Ratio for ALNY's Customers

You may also want to know
ALNY's Sales Growth Rates ALNY's Pe Price to earnings ratio ALNY's Receivables Turnover Ratio ALNY's Stock Quote
ALNY's Net Income Growth Rates ALNY's Ps Price to Sales ratio ALNY's Sales per Employee ALNY's Asset Turnover Ratio
ALNY's Net Margin ALNY's Pb Price to Book ratio ALNY's Financial Strength Ratios ALNY's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
Omada Health Inc   25.23 $ 94.184  Millions$ 4  Millions
Viemed Healthcare Inc   24.53 $ 121.559  Millions$ 5  Millions
Autolus Therapeutics Plc  23.69 $ 102.986  Millions$ 4  Millions
Sbc Medical Group Holdings Incorporated  22.54 $ 47.885  Millions$ 2  Millions
Lucid Diagnostics Inc   21.75 $ 9.858  Millions$ 0  Millions
Rosecliff Acquisition Corp I  21.00 $ 11.442  Millions$ 1  Millions
Teladoc Health Inc   20.90 $ 772.290  Millions$ 37  Millions
Agape Atp Corporation  20.80 $ 0.667  Millions$ 0  Millions
Labcorp Holdings Inc   19.53 $ 10,065.900  Millions$ 516  Millions
Edap Tms Sa  19.36 $ 64.760  Millions$ 3  Millions
Aspira Women s Health inc   19.29 $ 5.319  Millions$ 0  Millions
Adapthealth Corp   17.66 $ 2,686.512  Millions$ 152  Millions
Neuronetics Inc   17.04 $ 78.000  Millions$ 5  Millions
Precipio inc   15.93 $ 14.540  Millions$ 1  Millions
Rockwell Medical inc   15.34 $ 56.000  Millions$ 4  Millions
Aurinia Pharmaceuticals Inc   14.12 $ 30.596  Millions$ 2  Millions
Star Equity Holdings Inc   13.78 $ 106.877  Millions$ 8  Millions
Natera Inc   13.48 $ 869.958  Millions$ 65  Millions
Cryo cell International Inc   13.44 $ 7.049  Millions$ 1  Millions
The Oncology Institute Inc   11.17 $ 211.805  Millions$ 19  Millions
Genedx Holdings Corp   11.09 $ 135.000  Millions$ 12  Millions
Infusystem Holdings Inc  10.96 $ 61.593  Millions$ 6  Millions
Irhythm Holdings Inc   10.94 $ 228.000  Millions$ 21  Millions
Earth Science Tech Inc   10.81 $ 8.224  Millions$ 1  Millions
Option Care Health Inc   10.74 $ 4,579.720  Millions$ 427  Millions
Zevra Therapeutics Inc   10.44 $ 17.034  Millions$ 2  Millions
Alnylam Pharmaceuticals Inc   10.38 $ 814.503  Millions$ 78  Millions
Nutriband Inc   10.06 $ 1.291  Millions$ 0  Millions
Lantheus Holdings Inc   9.75 $ 610.000  Millions$ 63  Millions
Sotera Health Company  9.58 $ 531.000  Millions$ 55  Millions

Date modified: 2026-05-02T13:23:12+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.